Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 30,000 shares at $63.22 ($1.9M) on 2024-01-23, disclosed to the SEC on 2024-01-25.
Scheduled sale ($1.9M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.22 | 2,938 | $186K | 9.7% |
| 2 | $63.22 | 2,938 | $186K | 9.7% |
| 3 | $63.95 | 10,023 | $641K | 33.4% |
| 4 | $63.95 | 10,023 | $641K | 33.4% |
| 5 | $64.78 | 2,039 | $132K | 6.9% |
| 6 | $64.78 | 2,039 |
| $132K |
| 6.9% |
| Total | $63.92 avg | 30,000 | $1.9M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |